Next generation anti blood clot drug on the way
The race to find the next generation of treatments that prevent the formation of potentially fatal blood clots heated up when Boehringer Ingelheim announced positive Phase III trial results.
Archives for December 15, 2006
Genentech begins Alzheimer's Research
Genentech has decided to take an expensive short cut into the world of Alzheimer's research.
AQIX liquid preserves tissue life and function
Synthetic extra-cellular fluid maintains cell function and life while increasing pre-clinical trial reproducibility.
The changing face of allergy therapeutics
Oral immuno-therapies offer a cure, rather than just relief, to millions of hayfever sufferers worldwide.
Patients don't care about conflicts of interest
Most cancer patients participating in clinical trials only care about their health, not whether researchers have financial interests in its outcome.
GreeneChip for faster disease diagnosis
New technology provides unprecedented opportunities for unbiased pathogen discovery.